BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Isorhamnetin

the leaves of Elaeagnus pungens; structure in first source Heading Mapped to: Glycosides

300+ PubMed studies analyzed · 1 RCTs · Evidence Score: 36.6

Research Domains

Isorhamnetin has been studied across 27 research domains including 🔬 Oncology, 🔬 Inflammation, 🧘 Stress & Anxiety, 🫁 Liver & Detox, 🔥 Metabolic. The primary research focus is 🔬 Oncology with 34% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Isorhamnetin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

tamarixetin
8 shared targets
Hesperidin
11 shared targets
withaferin
9 shared targets
Kaempferols
10 shared targets
Acetaminophen
9 shared targets
Acetaminophen
9 shared targets
Kaempferols
18 shared targets
Sulfaphenazole
6 shared targets
eriodictyol
5 shared targets
4-Hydroxybenzoate-3-Monooxygenase
7 shared targets
Loading evidence profile...

This evidence profile for Isorhamnetin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.